Drug Discovery Today 2018-03-21

Computational modeling approaches to quantitative structure–binding kinetics relationships in drug discovery

Pier G. De Benedetti, Francesca Fanelli

Index: 10.1016/j.drudis.2018.03.010

Full Text: HTML

Abstract

Highlights • The interplay of kinetic rates and binding affinity is essential in drug design/discovery. • Examples of linear correlations between kinetic rates and binding affinity are reported. • QSKR models based on empirical and computational molecular descriptors are shown. • Computational approaches to decipher at the atomic detail drug-binding kinetics are reviewed. Simple comparative correlation analyses and quantitative structure–kinetics relationship (QSKR) models highlight the interplay of kinetic rates and binding affinity as an essential feature in drug design and discovery. The choice of the molecular series, and their structural variations, used in QSKR modeling is fundamental to understanding the mechanistic implications of ligand and/or drug–target binding and/or unbinding processes. Here, we discuss the implications of linear correlations between kinetic rates and binding affinity constants and the relevance of the computational approaches to QSKR modeling.

Latest Articles:

Design strategies for physical-stimuli-responsive programmable nanotherapeutics

2018-04-10

[10.1016/j.drudis.2018.04.003]

An operational model for GPCR homodimers and its application in the analysis of biased signaling

2018-04-09

[10.1016/j.drudis.2018.04.004]

The emerging role of copper-64 radiopharmaceuticals as cancer theranostics

2018-04-07

[10.1016/j.drudis.2018.04.002]

Update on the main use of biomaterials and techniques associated with tissue engineering

2018-03-30

[10.1016/j.drudis.2018.03.013]

Extension of quality-by-design concept to the early development phase of pharmaceutical R&D processes

2018-03-27

[10.1016/j.drudis.2018.03.012]

More Articles...